New Life Science Research Findings from Sungkyunkwan University Described (Trends in polypharmacy over 12 years and changes in its social gradients... - InsuranceNewsNet

InsuranceNewsNet

Sign in
  • Subscribe
  • About
  • Advertise
  • Contact
Home Now reading newswires
Topics
  • Life Insurance
  • Annuity News
  • Health/Employee Benefits
  • Property & Casualty
  • Advisor News
  • Washington Wire
  • Fiduciary Rule
  • INN Exclusives
  • Newswires
  • INNsider
  • INN Exclusives
  • NewsWires
  • Magazine
Sign in or register to be an INNsider.
  • INN Exclusives
  • NewsWires
  • ★ Regulation News
  • Podcast
  • Magazine
  • About
  • Advertise
  • Editorial Staff
  • Contact
  • Susbcribe

Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Google+
Insider
newswires
newswires RSS Get our newsletter
Order Prints Share
September 27, 2018 newswires No comments Views: 4

New Life Science Research Findings from Sungkyunkwan University Described (Trends in polypharmacy over 12 years and changes in its social gradients…

Drug Week

New Life Science Research Findings from Sungkyunkwan University Described (Trends in polypharmacy over 12 years and changes in its social gradients in South Korea)

By a News Reporter-Staff News Editor at Drug Week -- Fresh data on Life Science Research are presented in a new report. According to news reporting out of Gyeonggi Do, South Korea, by NewsRx editors, research stated, "Polypharmacy is associated with adverse drug reactions and represents an economic burden on the health insurance system. The objective of our study was to assess the trends in polypharmacy and its associated factors in South Korea."

Financial support for this research came from Korea Health Industry Development Institute (see also Life Science Research).

Our news journalists obtained a quote from the research from Sungkyunkwan University, "This cross-sectional study used a nationwide sampled database between 2002 and 2013, including outpatients of all ages who received at least 1 prescription in the same period. Polypharmacy was defined as the concomitant prescription of greater than or equal to6 distinct medications on a single prescription at least once without a given duration. The yearly prescribing trends were calculated and plotted. We conducted comparative analyses to identify the changes in social gradients of polypharmacy between the first 2 years, 2002-2003, and the final 2 years, 2012-2013. We repeated logistic regressions for pediatrics <20 years of age and adults greater than or equal to20 years of age to estimate the adjusted odds ratios (aOR) and 95% confidence intervals (CI). The distributions of polypharmacy in the respective periods were examined according to patient economic status (0=most deprived and 10=most affluent). The age-standardized prevalence of polypharmacy decreased from 65.8% in 2002 to 43.7% in 2013. Our study included 1,108,298 outpatients throughout 2002-2013. Pediatric patients aged 1-9 years had the highest number of medications among all age groups (mean: 5.1 ? 1.1 in 2002-2003 vs. 4.1 ? 1.1 in 2012-2013) in both periods. Changes in the association between deprivation and polypharmacy over 10 years were observed in adults (aOR=0.68; 95% CI=0.62-0.75 in 2002-2003 vs. 1.60; 95% CI=1.54-1.66 in 2012-2013) and pediatrics (aOR=0.60; 95% CI=0.52-0.68 in 2002-2003 vs. 1.07; 95% CI=1.01-1.14 in 2012-2013) compared with those in the most affluent patients."

According to the news editors, the research concluded: "The high level of polypharmacy in pediatric patients is a public health concern that warrants policymaker attention."

For more information on this research see: Trends in polypharmacy over 12 years and changes in its social gradients in South Korea. Plos One, 2018;13(9):e0204018. (Public Library of Science - www.plos.org; Plos One - www.plosone.org)

Our news journalists report that additional information may be obtained by contacting Y.H. Baek, School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do, South Korea.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.1371/journal.pone.0204018. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

Keywords for this news article include: Asia, Pediatrics, Gyeonggi Do, South Korea, Polypharmacy, Drugs and Therapies, Health and Medicine, Life Science Research.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2018, NewsRx LLC

Older

Advizr WorkPlace Wins Best 401k Technology – WealthManagement.com Industry Awards

Newer

T. Rowe Price Study Finds Strong Correlation Between Financial Performance of Companies and Quality of Their 401k Plans

Advisor News

  • MDRT Study Finds Consumers Want Advisors Over Tech
  • Your Clients Should Plan Retirement Savings To Last 23 Years
  • Robert Moore Steps Down As CEO Of Cetera, Due To Health Reasons
  • Financial Advisor Fined In $1M Scam
  • Mercer Advisors Acquires Arbor Asset Management
More Advisor News

Annuity News

  • Nick Lane Assumes Role As President Of AXA Equitable Life
  • Annuity Sales Spiked 14 Percent In 2018, No Slowdown In Sight
  • Speak Out: NAIC Gets Plenty Of Advice On Annuity Sales Rule
  • Lincoln Financial Introduces Annuity Designed For Retirement Rollover Dollars
  • IRI Urges NAIC To Proceed Cooperatively With SEC On Suitability
More Annuity News

Health/Employee Benefits

  • Government Headed For Close To Half The Nation’s Health Tab
  • National Health Expenditures To Hit $6T By 2027, CMS Predicts
  • Florida Governor Wants To Import Drugs From Canada
  • Dems Grapple With ‘Socialism’ Label On Health Care
  • One-in-Five U.S. Rural Hospitals At Risk Of Closing: Study
More Health/Employee Benefits

Life Insurance

  • AIG Sets New Term Life Insurance Rates
  • Northwestern Mutual Reports Strong 2018 Financial Results
  • Florida Police: Niece Steals $188,000, Life Insurance, From Aunt
  • P/C Broker Gallagher Widens Retirement Practice Into IMO Space
  • MDRT Study Finds Consumers Want Technology To Complement, Not Replace Human Advisors
Sponsor
More Life Insurance

Sign up for our FREE e-Newsletter!

Get breaking news, exclusive stories, and money- making insights straight into your inbox.
select Newsletter Options

Most Popular

  • Annuity Sales Spiked 14 Percent In 2018, No Slowdown In Sight
  • Understanding The Benefits Of Whole Life Insurance
  • Private Equity Targets Insurance Agencies For M&A Activity
  • What If The Market Goes Up? Why An FIA Is Better Than Stocks
  • How To Determine That Ideal IUL Prospect

Featured Offers

Text Ads

Press ReleasesAll press releases

  • LegacyShield® Launches MyTax, An Integrated Solution for Simplified, Professionally Prepared, Tax Returns
  • Nassau Re Launches Insurtech Incubator Will Give Space and Support to Startups in Hartford
  • Peerfit Prepares for Medicare Expansion with Peerfit Move, Recruits Industry Veteran
  • Great American’s Annuity Customers Share Their Secrets to a Great Retirement
  • Securian Financial Introduces Affordable, Protection-Focused IUL with No-Lapse Guarantee
Add your Press Release >

Topics

  • Life Insurance
  • Annuity News
  • Health/Employee Benefits
  • Property and Casualty News
  • Advisor News
  • Washington Wire
  • Regulation

Top Sections

  • INN Exclusives
  • INN Insider

Our Company

  • About
  • Editorial Staff
  • Advertise
  • Contact

Sign up for our FREE e-Newsletter!

Get breaking news, exclusive stories, and money- making insights straight into your inbox.

select Newsletter Options
Facebook Linkedin Twitter Google+
© 2019 InsuranceNewsNet.com, Inc. All rights reserved.
  • Terms & Conditions
  • Privacy Policy
  • Sitemap
  • AdvisorNews

Sign in with your INNsider Account

Not registered? Become an INNsider.